Synthesis, crystal structure, Hirshfeld surface analysis, MEP study and molecular docking of N-{3-[(4-methoxyphenyl)carbamoyl]phenyl}-3- nitrobenzamide as a promising inhibitor of hfXa

Tools

Moreno-Fuquen, Rodolfo and Hurtado-Angulo, Mario and Arango-Daravina, Kevin and Bain, Gavin and Kennedy, Alan R. (2020) Synthesis, crystal structure, Hirshfeld surface analysis, MEP study and molecular docking of N-{3-[(4-methoxyphenyl)carbamoyl]phenyl}-3- nitrobenzamide as a promising inhibitor of hfXa. Acta Crystallographica Section E: Structure Reports, E76 (11). pp. 1762-1767. ISSN 1600-5368 (https://doi.org/10.1107/S2056989020013730)

[thumbnail of Moreno-Fuquen-etal-CC-2020-Synthesis-crystal-structure-Hirshfeld-surface-analysis-MEP-study]
Preview
 Text. Filename: Moreno_Fuquen_etal_CC_2020_Synthesis_crystal_structure_Hirshfeld_surface_analysis_MEP_study.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (1MB)| Preview

Abstract

The title compound, C21H17N3O5, consists of three rings, A, B and C, linked by amide bonds with the benzene rings A and C being inclined to the mean plane of the central benzene ring B by 2.99 (18) and 4.57 (18)°, respectively. In the crystal, mol­ecules are linked via N - H⋯O and C - H⋯O hydrogen bonds, forming fused R 22(18), R 34(30), R 44(38) rings running along [ 0 ] and R 33(37) and R 33(15) rings along [001]. Hirshfeld analysis was undertaken to study the inter­molecular contacts in the crystal, showing that the most significant contacts are H⋯O/O⋯H (30.5%), H⋯C/C⋯H (28.2%) and H⋯H (29.0%). Two zones with positive (50.98 and 42.92 kcal mol-1) potentials and two zones with negative (-42.22 and -34.63 kcal mol-1) potentials promote the N - H⋯O inter­actions in the crystal. An evaluation of the mol­ecular coupling of the title compound and the protein with enzymatic properties known as human coagulation factor Xa (hfXa) showed the potential for coupling in three arrangements with a similar minimum binding energy, which differs by approximately 3 kcal mol-1 from the value for the mol­ecule Apixaban, which was used as a positive control inhibitor. This suggests the title compound exhibits inhibitory activity.

ORCID iDs

Moreno-Fuquen, Rodolfo, Hurtado-Angulo, Mario, Arango-Daravina, Kevin, Bain, Gavin and Kennedy, Alan R. ORCID logoORCID: https://orcid.org/0000-0003-3652-6015;
  • Item type:Article
    ID code:74349
    Dates:
    Date
    Event
    30 November 2020
    Published
    13 October 2020
    Accepted
    Subjects:Science > Chemistry
    Department:Faculty of Science > Pure and Applied Chemistry
    Depositing user: Pure Administrator
    Date deposited:23 Oct 2020 15:03
    Last modified:01 Jan 2025 17:50
    URI:https://strathprints.strath.ac.uk/id/eprint/74349
CORE (COnnecting REpositories)